-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
The endogenous production of nitric oxide (NO) plays a key role in many bioregulatory systems, including the control of vascular tone, inhibition of platelet aggregation, neurotransmission, and macrophage toxicity. Many of these pathways are activated by the stimulation of soluble guanylyl cyclase (
1
). Owing to the inconvenient handling of solutions of NO, there is an increased interest in compounds capable of generating NO
in situ
. These compounds can be divided into different groups that include organic nitrates [e.g., glyceryl trinitrate (GTN)], organic nitrites (e.g., iso amyl nitrite), inorganic nitroso compounds [e.g., sodium nitroprusside (SNP)], sydnonimines [e.g., molsidomine (SIN-1)], and S-nitrosothiols (RSNO) [e.g., S-nitrosoglutathione, (GSNO)]. All these compounds differ in their need for specific cofactors required to release NO (
2
).